Prelude Capital Management’s Immunogen Inc IMGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-157,856
| Closed | -$4.68M | – | 1468 |
|
|
2023
Q4 | $4.68M | Buy |
157,856
+56,541
| +56% | +$1.68M | 0.31% | 51 |
|
|
2023
Q3 | $1.61M | Buy |
101,315
+24,933
| +33% | +$396K | 0.1% | 187 |
|
|
2023
Q2 | $1.44M | Buy |
+76,382
| New | +$1.44M | 0.09% | 219 |
|
|
2019
Q3 | – | Sell |
-3,175
| Closed | -$7K | – | 1693 |
|
|
2019
Q2 | $7K | Buy |
+3,175
| New | +$7K | ﹤0.01% | 1082 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1845 |
|
|
2018
Q2 | – | Sell |
-2,200
| Closed | -$23K | – | 1735 |
|
|
2018
Q1 | $23K | Buy |
+2,200
| New | +$23K | ﹤0.01% | 1095 |
|
|
2017
Q4 | – | Sell |
-4,500
| Closed | -$34K | – | 1654 |
|
|
2017
Q3 | $34K | Buy |
+4,500
| New | +$34K | ﹤0.01% | 1094 |
|
|
2016
Q4 | – | Sell |
-12,700
| Closed | -$34K | – | 1774 |
|
|
2016
Q3 | $34K | Buy |
12,700
+7,050
| +125% | +$18.9K | ﹤0.01% | 1113 |
|
|
2016
Q2 | $17K | Sell |
5,650
-4,150
| -42% | -$12.5K | ﹤0.01% | 1269 |
|
|
2016
Q1 | $83K | Buy |
9,800
+4,500
| +85% | +$38.1K | 0.01% | 751 |
|
|
2015
Q4 | $72K | Hold |
5,300
| – | – | 0.01% | 876 |
|
|
2015
Q3 | $51K | Sell |
5,300
-600
| -10% | -$5.77K | 0.01% | 978 |
|
|
2015
Q2 | $85K | Sell |
5,900
-600
| -9% | -$8.64K | 0.01% | 872 |
|
|
2015
Q1 | $58K | Sell |
6,500
-8,000
| -55% | -$71.4K | 0.01% | 1172 |
|
|
2014
Q4 | $88K | Buy |
+14,500
| New | +$88K | 0.01% | 985 |
|
|
2014
Q2 | – | Sell |
-38,823
| Closed | -$580K | – | 2014 |
|
|
2014
Q1 | $580K | Buy |
38,823
+25,675
| +195% | +$384K | 0.08% | 295 |
|
|
2013
Q4 | $193K | Hold |
13,148
| – | – | 0.03% | 570 |
|
|
2013
Q3 | $224K | Sell |
13,148
-19,852
| -60% | -$338K | 0.04% | 443 |
|
|
2013
Q2 | $547K | Buy |
+33,000
| New | +$547K | 0.12% | 198 |
|